Provided by Tiger Trade Technology Pte. Ltd.

STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD

75.98
-2.5700-3.27%
Post-market: 75.40-0.5800-0.76%19:23 EST
Volume:415.27K
Turnover:31.56M
Market Cap:5.25B
PE:-20.80
High:79.10
Open:78.65
Low:74.34
Close:78.55
52wk High:94.90
52wk Low:13.22
Shares:69.14M
Float Shares:49.03M
Volume Ratio:0.38
T/O Rate:0.85%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.6529
EPS(LYR):-2.3276
ROE:-25.28%
ROA:-17.53%
PB:6.82
PE(LYR):-32.64

Loading ...

Septerna Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Yesterday

Obesity Drugmakers and Developers Fall After Rival Novo Nordisk Warns of Steep 2026 Sales Decline

THOMSON REUTERS
·
Feb 04

Structure Therapeutics Down 5.3%, Viking Therapeutics Down 3.3%, Amgen Down 1.4%

THOMSON REUTERS
·
Feb 04

Novo Nordisk Warns on Profits and Sales Amid Trump Drug Price Crackdown

Reuters
·
Feb 04

Structure Therapeutics emerges as top M&A target for big pharma, Axios says

TIPRANKS
·
Jan 30

Weight Loss Drugs Market Is Crowded But Structure Therapeutics CEO Has A Strategy For It

Benzinga_recent_news
·
Jan 23

Structure Therapeutics Inc : JP Morgan Raises Target Price to $105 From $65

THOMSON REUTERS
·
Jan 22

Structure Therapeutics, Inc. Sponsored ADR (GPCR) Gets a Buy from Goldman Sachs

TIPRANKS
·
Jan 20

24H | Springview Rockets Another 16% After a 674% Rally; GPCR Jumps 6% as It Expects Pills to Capture up to 50% of GLP-1 Obesity Market; Hesai Gains 3%

Tiger Newspress
·
Jan 16

Structure Therapeutics CEO Says Compounding Threat Looms For Future Obesity Treatments

Benzinga_recent_news
·
Jan 16

Structure Therapeutics CEO Voices Concerns Over Generic Competition for Weight-Loss Drugs: Challenges Loom Even Before Market Approval

Stock News
·
Jan 15

Structure expects pills to capture up to 50% of GLP-1 obesity market by 2030

Reuters
·
Jan 15

Structure Therapeutics CEO Expects Pills to Capture 25% to 50% of Glp-1 Weight-Loss Market by 2030

THOMSON REUTERS
·
Jan 15

Structure Therapeutics CEO Says Strategic Partner for Commercialization of Its Medicine Needs to Have Strong Relationships With Primary Care Doctors

THOMSON REUTERS
·
Jan 15

What to Watch in the Day Ahead - Wednesday, January 14

Reuters
·
Jan 14

Structure Therapeutics rises 14.1%

TIPRANKS
·
Jan 14

What to Watch in the Day Ahead - Tuesday, January 13

Reuters
·
Jan 13

Funding for Risky Biotechs Is Returning -- WSJ

Dow Jones
·
Jan 13

Structure Therapeutics Inc. unveils oral obesity treatment pipeline in new corporate presentation

Reuters
·
Jan 13

Septerna to Present GPCR Pipeline Updates at JPM Conference

TIPRANKS
·
Jan 12